Home Companies Catalysts Deep Dives
Efinopegdutide MK-6024 PHASE3
Drug Profile
ModalityPeptide
RouteSC
Therapy AreaCVRM
Peak Sales Est$3000M
Formulations[]
Companies
MRK (ORIGINATOR)100%
Mechanism: GLP-1/glucagon dual agonist
Expert: Dual agonist of GLP-1 and glucagon receptors
Everyday: Mimics two hormones for weight and liver fat loss
Targets: ["GLP-1","GCGR"]
Programs (1)
IndicationStageKey StudyRegional Status
MASHPHASE3ESSENCE[]
Notes
GLP-1/glucagon dual agonist for MASH. Differentiated mechanism from pure GLP-1s.
Data from Supabase · Updated 2026-03-24